(NYSE: AVNT) Avient's forecast annual revenue growth rate of 4.25% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.82%.
Avient's revenue in 2026 is $3,281,000,000.On average, 11 Wall Street analysts forecast AVNT's revenue for 2026 to be $314,565,872,810, with the lowest AVNT revenue forecast at $299,158,564,754, and the highest AVNT revenue forecast at $332,449,355,375. On average, 11 Wall Street analysts forecast AVNT's revenue for 2027 to be $325,937,933,518, with the lowest AVNT revenue forecast at $308,513,001,788, and the highest AVNT revenue forecast at $344,279,966,918.
In 2028, AVNT is forecast to generate $340,978,400,906 in revenue, with the lowest revenue forecast at $323,553,469,176 and the highest revenue forecast at $357,761,361,467.